The National Reconstruction Fund has taken a $54 million stake in Synchron, the Melbourne-founded startup developing a non-invasive brain-computer interface that rivals Elon Musk’s Neuralink, as part of a...
Melbourne-founded brain-computer interface company Synchron is expecting to complete its early feasibility study by the end of this year, but will need more capital to secure regulatory approval in...
Spun out by researchers at the University of Melbourne, brain-computer interface company Synchron this week became the first company to begin clinical trials in the United States, ahead of...